Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridostigmine for Post-BoNT Dysphonia in Spasmodic Dysphonia
NCT05110417Phase 4Unknown
- Sponsor
- Eastern Virginia Medical School
- Start
- May 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pyridostigmine in dysphonia, sponsored by Eastern Virginia Medical School. Status: unknown.
02
Drugs
pyridostigmine
03
Conditions
dysphonia
Beyond the preview
Go deeper on NCT05110417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05110417.